Gnosis Health Secures £1.1m Investment to Advance Parkinson’s Technology

A pioneering health technology company based at The Catalyst, Gnosis Health, has secured £1.1 million in funding to accelerate the development of its digital solution aimed at transforming the management of Parkinson’s disease.

The investment marks an important milestone for the Newcastle University and Plymouth University spin-out, as it continues to move from academic research into real-world healthcare impact.

Advancing Patient-Centred Digital Healthcare

At the heart of Gnosis Health’s work is MAXine, an AI-powered digital healthcare assistant designed to support people living with Parkinson’s disease.

MAXine brings together data from wearable devices, patient-reported outcomes and behavioural patterns to provide real-time insights for both patients and clinicians. By enabling continuous monitoring, the platform supports better self-management while improving communication with care teams.

This approach addresses a critical gap in Parkinson’s care, where symptoms can fluctuate daily but clinical interactions are often limited.

Backed by Strong Investment and Regional Support

The £1.1m funding package includes backing from Northstar Ventures, SFC Capital, and Innovate UK, alongside support from the wider North East innovation ecosystem.

Initiatives such as the North East Spinout Inspire Fund and Northern Accelerator have played a key role in helping companies like Gnosis Health transition from early-stage research into commercial ventures.

From Research to Real-World Impact

Gnosis Health brings together expertise in artificial intelligence, software engineering and clinical research to tackle one of healthcare’s most pressing challenges—improving the management of chronic conditions.

With more than 150,000 people in the UK living with Parkinson’s, the need for more responsive and personalised care is clear. Early findings suggest that continuous digital monitoring solutions like MAXine could improve patient outcomes while also reducing care costs.

Growing Innovation at The Catalyst

Gnosis Health is part of the vibrant community at The Catalyst, located within the Newcastle Helix innovation district. The building brings together forward-thinking businesses, researchers and organisations working at the forefront of ageing and data science.

As operators of The Catalyst on behalf of Newcastle University, we are proud to support innovative companies like Gnosis Health as they grow, collaborate and bring impactful solutions to market.

Supporting the Future of Health Innovation

The success of Gnosis Health highlights the strength of collaboration between academia, industry and the regional investment community.

By providing the environment, connections and support needed to scale, The Catalyst continues to play a key role in enabling businesses to turn cutting-edge ideas into meaningful outcomes.

To learn more, visit the original Newcastle University Newcastle Innovations article.